Literature DB >> 10030390

Upregulation of cholesterol synthesis after acute myocardial infarction--is cholesterol a positive acute phase reactant?

M Pfohl1, I Schreiber, H M Liebich, H U Häring, H M Hoffmeister.   

Abstract

Acute myocardial infarction is associated with profound alterations in the plasma lipoprotein profile. The mechanism of these alterations is not clear, and both cholesterol biosynthesis up- and downregulation could possibly be a consequence of acute myocardial infarction. We determined plasma lipids, lipoproteins, apolipoproteins, and lathosterol-which is regarded as an estimate of whole body cholesterol biosynthesis in humans-concentrations in 34 patients (age 68+/-10 years, 24 male, 10 female) admitted to our hospital with acute MI and with onset of symptoms within the last 12 h. Samples were taken immediately after admission to the hospital, and 1, 2, and 10 days after admission. On the first day after admission there was a decrease in total cholesterol (C) by 14.1%, (P = 0.01), in LDL-C by 14.4% (P = 0.03), in HDL-C by 9.3% (NS), and in triglycerides by 19.5% (NS). Apolipoprotein B100 was reduced by 18.3% (P = 0.008), and apolipoprotein AI by 12.3% (NS). The lathosterol/cholesterol ratio was increased by 23.1% after 1 day, and by 28.7% after 2 days (P = 0.05). After 10 days, all variables except the apolipoproteins had essentially returned to baseline values. In conclusion, the changes in the plasma lipid profile after acute myocardial infarction are associated with a profound increase of whole body cholesterol biosynthesis as judged by the lathosterol/cholesterol ratio. These changes may possibly enhance the delivery of cholesterol to cells involved in tissue repair mechanisms after acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030390     DOI: 10.1016/s0021-9150(98)00242-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

1.  Innate and acquired immunity intersect in a global view of the acute-phase response.

Authors:  Joo-Yeon Yoo; Stephen Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

2.  Paradoxical impact of decreased low-density lipoprotein cholesterol level at baseline on the long-term prognosis in patients with acute coronary syndrome.

Authors:  Takuya Nakahashi; Hayato Tada; Kenji Sakata; Yohei Yakuta; Yoshihiro Tanaka; Akihiro Nomura; Tadatsugu Gamou; Hidenobu Terai; Yuki Horita; Masatoshi Ikeda; Masanobu Namura; Masayuki Takamura; Kenshi Hayashi; Masakazu Yamagishi; Masa-Aki Kawashiri
Journal:  Heart Vessels       Date:  2017-12-29       Impact factor: 2.037

Review 3.  Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.

Authors:  Jeffrey W Meeusen; Leslie J Donato; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

4.  Changes in plasma LDL and HDL composition in patients undergoing cardiac surgery.

Authors:  M Hacquebard; A Ducart; D Schmartz; W J Malaisse; Y A Carpentier
Journal:  Lipids       Date:  2007-10-03       Impact factor: 1.880

5.  Total cholesterol and LDL levels decrease before rheumatoid arthritis.

Authors:  Elena Myasoedova; Cynthia S Crowson; Hilal Maradit Kremers; Patrick D Fitz-Gibbon; Terry M Therneau; Sherine E Gabriel
Journal:  Ann Rheum Dis       Date:  2009-10-23       Impact factor: 19.103

6.  Serum lipid profile in patients with acute myocardial infarction.

Authors:  P K Nigam; V S Narain; M Hasan
Journal:  Indian J Clin Biochem       Date:  2004-01

Review 7.  The modification of serum lipids after acute coronary syndrome and importance in clinical practice.

Authors:  Bahattin Balci
Journal:  Curr Cardiol Rev       Date:  2011-11

8.  Prevalence, Predictors, and Impact of Low High-Density Lipoprotein Cholesterol on in-Hospital Outcomes Among Acute Coronary Syndrome Patients in the Middle East.

Authors:  Khalid Al-Rasadi; Ibrahim Al-Zakwani; Mohammad Zubaid; Amr Ali; Yasser Bahnacy; Kadhim Sulaiman; Wael Al Mahmeed; Jassim Al Suwaidi; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2011-08-30

9.  The role of dyslipidemia and statins in venous thromboembolism.

Authors:  Joel G Ray; Frits R Rosendaal
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

10.  Lipid profile of patients with acute myocardial infarction and its correlation with systemic inflammation.

Authors:  Haseeb A Khan; Abdullah S Alhomida; Samia H Sobki
Journal:  Biomark Insights       Date:  2013-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.